Buyers in a hot hospice M&A market are bringing compliance under a microscope as regulators keep a tight watch. All hospice transactions undergo some type of compliance review. But there’s nothing routine about these reviews in today’s current hospice regulatory environment. Combing through a hospice’s referral streams and financial or claims data can help identify […]
Maryland-based hospice and palliative care provider Gilchrist recently formed a joint venture with the hospital system Luminis Health to expand the full scope of senior and geriatric care in the state’s southern region. Through the JV, the two organizations formed the Luminis Health Gilchrist Lifecare Institute as a way to provide an “integrative continuum of […]
Hospices considering a sale should not underestimate their value proposition by limiting their focus to revenues and margins. With hospice M&A staying hot, a host of operational and financial pressures — coupled with record-high valuations in the space — has driven a range of providers to consider selling. While a healthy balance sheet is critical […]
Hospice acquisition volumes and price tags have hit record highs for several years running. Now, the companies that performed well under the pandemic’s pressure may be drawing more interest from buyers. While a sizzling hospice market saw a cooled start this year, merger and acquisition activity is still outpacing other health care sectors. Demographic tailwinds, […]
Two Oregon locations included in Humana’s (NYSE: HUM) divestiture of Kindred at Home’s hospice assets are currently under review by the state’s health authority — part of the diligence process involved in any M&A transaction. Humana in April signed a definitive agreement to sell a 60% stake in Kindred at Home to private equity firm […]
Private equity firms are pouring investment dollars into hospices at a record pace. Meanwhile, legislators and regulators as far up as the White House are taking aim at those firms. Despite a cool down in the hospice mergers and acquisitions market during the first quarter of 2022, private equity firms have stayed aggressive on deals. […]
More hospitals and health systems are stepping into the home-based hospice space, often seeing joint ventures as a promising route to a return on their investment. While there are several factors driving facility-based health care organizations to eye home-based care, more than anything, hospices and other providers should simply be aware that the “normal” look […]
Private equity (PE) firms represent the strongest competitors for strategic buyers in the hospice mergers-and-acquisitions market. Hospice M&A activity cooled off across the board during the first quarter of 2022. In part, this is because a range of buyers scrambled to complete deals during late 2021 and are now focused on integrating those assets. But […]
Humana Inc. (NYSE: HUM) has signed a definitive agreement to sell a 60% stake in Kindred at Home’s (KAH) hospice and personal care business to the private equity firm Clayton, Dubilier & Rice (CDR) for $2.8 billion. Humana will retain the remaining 40%. Kindred at Home has been on a circuitous journey with Humana. The […]
Deal volume in hospice and home health took a dive during the first quarter of 2022, though the dollar amounts in those acquisitions appear to be rising. A total of 30 transactions occurred during Q1 this year in the hospice and home health space, compared to 41 deals in Q4 of last year, according to […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
